Colorectal Cancer with the BRAF V600E Mutation: Two Case Reports and Literature Review

被引:0
|
作者
Pham, Nguyen Cuong [1 ]
Ho, Van Linh [2 ]
Ton-Nu, Victoria [3 ]
Ngo, Minh Tri [4 ]
Nguyen, Huu Son [5 ]
机构
[1] Hue Cent Hosp, Pathol Dept, Hue City, Vietnam
[2] Hue Cent Hosp, Digest Surg Dept, Hue City, Vietnam
[3] Univ Calif Irvine, Irvine, CA USA
[4] Hue Cent Hosp, Dept Radiol, Hue City, Vietnam
[5] Hue Cent Hosp, Pediat Ctr, Hue City, Vietnam
关键词
rectal cancer; RAS genes; BRAF V600E mutation; FOLFIRI PLUS BEVACIZUMAB; PHASE-II TRIAL; 1ST-LINE TREATMENT; RAS MUTATIONS; COLON-CANCER; POOLED ANALYSIS; BRAF-MUTATION; CETUXIMAB; KRAS; OXALIPLATIN;
D O I
10.21103/Article14(3)_CRI
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Colorectal cancer usually develops from stepwise, multiple mutations involving oncogenes and tumor suppressor genes. Mutations in the BRAF and RAS genes that dysregulate MAPK signaling are strongly associated with human malignancies. Colorectal cancer with the BRAF V600E mutation that causes cell proliferation without the need for growth factors has a worse prognosis than those without mutations. A BRAF V600E mutation was identified as an adverse prognostic factor for progression-free and overall survival. In this study, we analyze two cases of colorectal cancer with the BRAF V600E mutation and the literature data to investigate potential pathophysiologic mechanisms underlying metastatic colorectal cancer.
引用
收藏
页数:182
相关论文
共 50 条
  • [21] Immunohistochemical analysis of BRAF V600E antibody in colorectal cancer
    Ben Rejeb, S.
    Sakly, S.
    Bahloul, R.
    Souai, F.
    Chouch, A.
    VIRCHOWS ARCHIV, 2024, 485 : S471 - S472
  • [22] Detection of BRAF V600E mutation by pyrosequencing
    Tan, Yi Hui
    Liu, Yanqun
    Eu, Kong Weng
    Ang, Pei Woon
    Li, Wei Qi
    Salto-Tellez, Manuel
    Iacopetta, Barry
    Soong, Richie
    PATHOLOGY, 2008, 40 (03) : 295 - 298
  • [23] Absence of the BRAF V600E mutation in pheochromocytoma
    Johan O. Paulsson
    F. Svahn
    J. Welander
    L. Brunaud
    P. Söderkvist
    O. Gimm
    A. Stenman
    C. C. Juhlin
    Journal of Endocrinological Investigation, 2016, 39 : 715 - 716
  • [24] Targeted Therapy for BRAF V600E Positive Pancreatic Adenocarcinoma: Two Case Reports
    Shah, Shivani
    Rana, Tabeer
    Kancharla, Pragnan
    Monga, Dulabh
    CANCER GENOMICS & PROTEOMICS, 2023, 20 (04) : 398 - 403
  • [25] Absence of the BRAF V600E mutation in pheochromocytoma
    Paulsson, Johan O.
    Svahn, F.
    Welander, J.
    Brunaud, L.
    Soderkvist, P.
    Gimm, O.
    Stenman, A.
    Juhlin, C. C.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2016, 39 (06): : 715 - 716
  • [26] Vemurafenib in Melanoma with BRAF V600E Mutation
    Morita, Hiroyuki
    Nagai, Ryozo
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (15): : 1448 - 1448
  • [27] BRAF V600E MUTATION IN PEDIATRIC ASTROBLASTOMAS
    Antonelli, Manila
    Nizza, Paolo
    Gardiman, Marina P.
    Buttarelli, Francesca R.
    Cerati, Michele
    Milanaccio, Claudia
    Coli, Antonella
    Massimino, Maura
    Pollo, Bianca
    Moi, Loredana
    Badiali, Manuela
    Giangaspero, Felice
    NEURO-ONCOLOGY, 2016, 18 : 50 - 50
  • [28] BRAF V600E Immunohistochemistry in Colorectal Carcinoma
    Estrella, J. S.
    Tetzlaff, M. T.
    Kazen, C.
    Kopetz, S.
    Maru, D. M.
    Rashid, A.
    Hamilton, S. R.
    Broaddus, R. R.
    MODERN PATHOLOGY, 2014, 27 : 173A - 173A
  • [29] BRAF V600E Immunohistochemistry in Colorectal Carcinoma
    Estrella, J. S.
    Tetzlaff, M. T.
    Kazen, C.
    Kopetz, S.
    Maru, D. M.
    Rashid, A.
    Hamilton, S. R.
    Broaddus, R. R.
    LABORATORY INVESTIGATION, 2014, 94 : 173A - 173A
  • [30] Rectal pleomorphic giant cell carcinoma combined with BRAF (V600E) mutation: A case report and literature review
    Lv, Yaochun
    Zhang, Jipeng
    Du, Binbin
    Yang, Xiongfei
    ASIAN JOURNAL OF SURGERY, 2025, 48 (03) : 1738 - 1739